---
document_datetime: 2026-02-23 15:18:57
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/ogivri-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: ogivri-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 3.019111
conversion_datetime: 2026-02-25 11:32:10.666843
docling_version:
  docling-serve: 1.13.1
  docling-jobkit: 1.11.0
  docling: 2.74.0
  docling-core: 2.65.2
  docling-ibm-models: 3.11.0
  docling-parse: 5.3.4
  python: cpython-313 (3.13.11)
  plaform: macOS-26.3-arm64-arm-64bit-Mach-O
---
## Ogivri

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|----------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Article 61(3) /      | - Notification acc. Article 61(3) - Accepted | 20/02/2026                          |                                             | PL                               |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                                       | Update of the package leaflet with revised contact details of local representatives.                                                                                                                                                                                                                                                                                                                                                                   |            | EMA/N/0000326197   |
|---------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|--------------------|
| Variation type IB / EMA/VR/0000325253 | This was an application for a group of variations. Q.II.d.2 Change to analytical procedure for the finished product - Q.II.d.2.a) Minor change to an approved analytical procedure - Accepted Q.I.b.2 Change to analytical procedure for active substance or starting material/reagent/intermediate used in the manufacturing process of the active substance - Q.I.b.2.a) Minor change to an analytical procedure for the active substance - Accepted | 13/02/2026 |                    |
| Variation type IA / EMA/VR/0000320798 | This was an application for a group of variations. B.II.e.7 Change in supplier of packaging components or devices (when mentioned in the dossier) - B.II.e.7.a Change in the name of a supplier of a packaging component. If the information is not needed in the dossier CMDh recommends deletion of this information. - Accepted B.II.e.7 Change in supplier of packaging components or devices (when mentioned in                                   | 07/01/2026 |                    |

<div style=\"page-break-after: always\"></div>

|                                       | the dossier) - B.II.e.7.a Change in the name of a supplier of a packaging component. If the information is not needed in the dossier CMDh recommends deletion of this information. - Accepted B.I.b.2 Change in test procedure for active substance or starting material/reagent/intermediate used in the manufacturing process of the active substance - B.I.b.2.b Deletion of a test procedure for the active substance or a starting material/reagent/ intermediate, if an alternative test procedure is already authorised. - Accepted B.III.2 Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - B.III.2.z To reflect compliance with the Ph.Eur. and remove reference to the internal test method and test method number for active substances, excipients, active substance starting materials and   |            |
|---------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|
| Variation type IB / EMA/VR/0000286249 | B.I.b.2 Change in test procedure for active substance or starting material/reagent/intermediate used in the manufacturing process of the active substance - B.I.b.2.a Minor changes to an approved test procedure - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 28/07/2025 |

<div style=\"page-break-after: always\"></div>

| Variation type IA / EMA/VR/0000288059   | B.I.b.2 Change in test procedure for active substance or starting material/reagent/intermediate used in the manufacturing process of the active substance - B.I.b.2.a Minor changes to an approved test procedure - Accepted   | 25/07/2025   |                   |
|-----------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------------------|
| Variation type IB /                     | B.I.a.2 Changes in the manufacturing process of the active substance - B.I.a.2.a Minor change in the manufacturing process of the active substance - Accepted                                                                  | 01/04/2025   | EMA/VR/0000258627 |